All Posts Tagged With: "CFN"
(OMCL) Omnicell Analyst Reaffirms Shares at Neutral
We recently reiterated our Neutral recommendation on Omnicell (OMCL) with a target price of $17.00. Omnicell reported adjusted EPS of 9 cents in the third quarter of fiscal 2011, beating the Zacks Consensus Estimate by a penny and the year-ago quarter EPS of 4 cents. Revenues...
14Dec2011 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Analyst Maintains Outperform on Shares
We reiterate our Outperform rating on Cardinal Health (CAH). Its first-quarter fiscal 2012 (ended September 30) adjusted earnings per share of 73 cents beat the Zacks Consensus Estimate of 72 cents. Earnings from continuing operations (as reported) dropped about 19% year over...
7Dec2011 | vitalstocks | 0 comments | Continued(OMCL) Omnicell’s G4 Platform Reaches China
Recently, Omnicell (OMCL) announced the launch of Mandarin-language versions of its G4 platform for clinical use in China. Following the launch of G4 medication automation platform in English-speaking markets earlier this year, the language conversion of medication cabinets will...
30Nov2011 | vitalstocks | 0 comments | Continued(OMCL) Omnicell Beats Estimates
Omnicell Inc. (OMCL) reported EPS of 9 cents during the second quarter of fiscal 2011, beating both the Zacks Consensus Estimate of 8 cents and the year-ago quarter EPS of 4 cents. Reported earnings shot up 125% on a year-over-year basis primarily due to the reduction in effective...
4Nov2011 | vitalstocks | 0 comments | Continued(OMCL) Omnicell Analyst Maintains Neutral on Shares
We recently reiterated our Neutral recommendation on Omnicell (OMCL) with a target price of $16.00. Omnicell reported an adjusted EPS of 8 cents in the second quarter of fiscal 2011, beating both the Zacks Consensus Estimate and the year-ago quarter’s EPS of 6 cents. Total...
20Sep2011 | vitalstocks | 0 comments | Continued(AOL) Company News for August 10, 2011 – Corporate Summary
• AOL (NYSE:AOL) reported a loss Q2 EPS of $0.11, against the Zacks Consensus Estimate of a profit of $0.02 per share. Revenues for the quarter declined by 8% to $542.2 million• Snyder’s-Lance (NASDAQ:LNCE) posted Q2 EPS of $0.16, ex-items, missing the Zacks...
10Aug2011 | vitalstocks | 0 comments | Continued(CFN) CareFusion Buying Rowa for $150 Million
Medical technology company CareFusion Corporation (CFN) recently made a deal to buy German medication storage systems maker Rowa GmbH for roughly $150 million. Rowa, which has customers in 30 countries, specializes in high-speed robotic medication storage and retrieval systems...
12Jul2011 | vitalstocks | 0 comments | Continued(OMCL) Omnicell’s Electronic Health Record Wins Certification
Omnicell, Inc. (OMCL), a leading developer and marketer of end-to-end automation solutions for the medication-use process, recently announced that its newly launched G4 platform received the ONC-ATCB certification as a Modular Electronic Health Record (“EHR”). Omnicell...
22Jun2011 | vitalstocks | 0 comments | Continued(OMCL) Omnicell Earns Second Consecutive Best in Klas Award
Omnicell (OMCL), recently announced that it has received recognition for its OmniRx automated dispensing system from leading research firm, KLAS for the second consecutive year. Along with the 2011 “Best in KLAS” award for Automated Medication Dispensing Units for...
19Jun2011 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Third Quarter 2011 Earnings Preview
Cardinal Health (CAH) is slated to report its third-quarter fiscal 2011 (ending March) results on Thursday, April 28. The company expects earnings per share in the range of $2.54 to $2.60 for fiscal 2011. The current Zacks Consensus Estimate for revenues and earnings for the...
27Apr2011 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Gets Antitrust Clearance
Cardinal Health (CAH) recently announced that antitrust regulators had cleared its $1.3 billion takeover of Kinray, a leading pharma distributor with a presence in the New York metropolitan area. In this regard, the Federal Trade Commission (“FTC”) had approved early termination...
20Dec2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Announces Buy of Kinray
Cardinal Health (CAH) recently announced plans to purchase Kinray Inc., a leading pharma distributor with a presence in the New York metropolitan area. The cash deal will enhance Cardinal’s capability to cater to retail independent pharmacies in the northeastern U.S. markets....
19Dec2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Prepares for Coming Flu Season
Cardinal Health (CAH) is taking necessary steps to maintain the supply of influenza vaccines during the forthcoming 2010-2011 flu season. For the first time, the Advisory Committee on Immunization Practices (ACIP) has been asking everyone over 6 months of age to get a flu vaccine....
3Oct2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Sells Remaining CareFusion Shares
Cardinal Health (CAH), a leading distributor of pharmaceuticals and medical supplies, recently sold off the remaining 30.5 million shares of CareFusion Corporation (CFN) for $705.9 million. CareFusion, a San Diego-based vendor for medical equipment and infection control supplies,...
19Sep2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Earnings Scorecard
Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies, recently reported earnings for fourth-quarter of fiscal year 2010, which beat the Zacks Consensus Estimate by a penny. Revenues grew by a mere 0.5% year over year to $22.3 billion....
11Aug2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health’s Report Beats Expectations by a Penny
Cardinal Health (CAH) reported fourth-quarter and fiscal 2010 adjusted (excluding one-time expenses) earnings per share of 50 cents and $2.22 respectively, exceeding the Zacks Consensus Estimates of 49 cents and $2.21, respectively, but below the year-ago results of 63 cents...
6Aug2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Earnings Preview
Cardinal Health (CAH) is slated to report fourth-quarter and fiscal 2010 (ending June 30, 2010) results on Thursday, August 5, 2010. The company earlier issued earnings per share guidance in the range of $2.15 to $2.20 for fiscal 2010. The current Zacks Consensus Estimate for...
2Aug2010 | vitalstocks | 0 comments | Continued(HSP) Hospira Second Quarter 2010 Earnings Preview
Hospira Inc. (HSP) is scheduled to report its second quarter 2010 results on Wednesday, July 28, before the opening bell. The Zacks Consensus Estimate for the quarter is earnings of 79 cents per share (with an upside of 2.53%), compared with earnings of 73 cents per share in...
2Aug2010 | vitalstocks | 0 comments | Continued(CFN) CareFusion Decides to Acquire Medegen for $225 Million
CareFusion Corporation (CFN) has decided to acquire Medegen for $225 million in cash. CareFusion expects the acquisition to be neutral to the adjusted earnings per share in the first year of operations and increasingly accretive thereafter. The acquisition is expected to be completed...
7Apr2010 | vitalstocks | 0 comments | Continued(CFN) CareFusion Corporation Beats Consensus Estimates
CareFusion Corporation (CFN) recently reported second quarter fiscal 2010 earnings per share of 39 cents, marginally beating the Zacks Consensus Estimate of 38 cents, but lower than the year-ago earnings of 50 cents. Total revenues in the second quarter increased 5% year over...
10Feb2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Upgraded to Outperform
We have recently upgraded Cardinal Health Inc. (CAH) to “Outperform” with a target price of $37 based on approximately 15.7x our fiscal 2011 EPS estimate of $2.36. Cardinal Health reported second quarter fiscal 2010 earnings per share of 57 cents, beating the Zacks Consensus...
10Feb2010 | vitalstocks | 0 comments | Continued(FOSL) Flies in the Ointment
We had several e-mails over the recent holidays asking what we did with research for companies we had decided not to pursue and would we consider sharing that research with others. Unlike most folks, we do not use stock screens. We see something on the web, or read something...
2Feb2010 | Wax | 0 comments | Continued(CFN) CareFusion Corporation Enters Agreement with Masimo
CareFusion Corp. (CFN) entered into a multi-year technology licensing agreement with Masimo Corp. (MASI) regarding the use of Masimo Rainbow SET Pulse CO-Oximetry technology in CareFusion infusion and respiratory products, which are presently under development. The agreement...
14Nov2009 | vitalstocks | 0 comments | Continued